These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
239 related articles for article (PubMed ID: 21619671)
21. MCM7 affects the cisplatin resistance of liver cancer cells and the development of liver cancer by regulating the PI3K/Akt signaling pathway. Su D Immunopharmacol Immunotoxicol; 2022 Feb; 44(1):17-27. PubMed ID: 34821526 [TBL] [Abstract][Full Text] [Related]
22. MCM7 expression predicts post-operative prognosis for hepatocellular carcinoma. Zhou YM; Zhang XF; Cao L; Li B; Sui CJ; Li YM; Yin ZF Liver Int; 2012 Nov; 32(10):1505-9. PubMed ID: 22784096 [TBL] [Abstract][Full Text] [Related]
23. Diagnostic and prognostic value of cell-cycle regulatory genes in malignant thyroid neoplasms. Kebebew E; Peng M; Reiff E; Duh QY; Clark OH; McMillan A World J Surg; 2006 May; 30(5):767-74. PubMed ID: 16547620 [TBL] [Abstract][Full Text] [Related]
24. MCM7 interacts with androgen receptor. Shi YK; Yu YP; Zhu ZH; Han YC; Ren B; Nelson JB; Luo JH Am J Pathol; 2008 Dec; 173(6):1758-67. PubMed ID: 18988800 [TBL] [Abstract][Full Text] [Related]
25. EZH2, Ki-67 and MCM7 are prognostic markers in prostatectomy treated patients. Laitinen S; Martikainen PM; Tolonen T; Isola J; Tammela TL; Visakorpi T Int J Cancer; 2008 Feb; 122(3):595-602. PubMed ID: 17943722 [TBL] [Abstract][Full Text] [Related]
26. Overexpression of G9a and MCM7 in oesophageal squamous cell carcinoma is associated with poor prognosis. Zhong X; Chen X; Guan X; Zhang H; Ma Y; Zhang S; Wang E; Zhang L; Han Y Histopathology; 2015 Jan; 66(2):192-200. PubMed ID: 24805087 [TBL] [Abstract][Full Text] [Related]
27. The protein levels of MCM7 and p63 in evaluating lesion severity of cervical disease. Zhang J; Wang L; Qiu M; Liu Z; Qian W; Yang Y; Wu S; Feng Y Int J Gynecol Cancer; 2013 Feb; 23(2):318-24. PubMed ID: 23318911 [TBL] [Abstract][Full Text] [Related]
29. Expression of minichromosome maintenance proteins in vascular smooth muscle cells is ERK/MAPK dependent. Bruemmer D; Yin F; Liu J; Kiyono T; Fleck E; Van Herle AJ; Law RE Exp Cell Res; 2003 Oct; 290(1):28-37. PubMed ID: 14516785 [TBL] [Abstract][Full Text] [Related]
30. Simvastatin exerts anti-hepatitis B virus activity by inhibiting expression of minichromosome maintenance protein 7 in HepG2.2.15 cells. Li W; Cao F; Li J; Wang Z; Ren Y; Liang Z; Liu P Mol Med Rep; 2016 Dec; 14(6):5334-5342. PubMed ID: 27779671 [TBL] [Abstract][Full Text] [Related]
31. MCM7 silencing promotes cutaneous melanoma cell autophagy and apoptosis by inactivating the AKT1/mTOR signaling pathway. Yang Y; Ma S; Ye Z; Zhou X J Cell Biochem; 2020 Feb; 121(2):1283-1294. PubMed ID: 31535400 [TBL] [Abstract][Full Text] [Related]
32. Characterization of a cleavage stimulation factor, 3' pre-RNA, subunit 2, 64 kDa (CSTF2) as a therapeutic target for lung cancer. Aragaki M; Takahashi K; Akiyama H; Tsuchiya E; Kondo S; Nakamura Y; Daigo Y Clin Cancer Res; 2011 Sep; 17(18):5889-900. PubMed ID: 21813631 [TBL] [Abstract][Full Text] [Related]
33. MicroRNA-100 is a potential molecular marker of non-small cell lung cancer and functions as a tumor suppressor by targeting polo-like kinase 1. Liu J; Lu KH; Liu ZL; Sun M; De W; Wang ZX BMC Cancer; 2012 Nov; 12():519. PubMed ID: 23151088 [TBL] [Abstract][Full Text] [Related]
34. Interaction of MCM7 and RACK1 for activation of MCM7 and cell growth. Zhang XY; Tang LZ; Ren BG; Yu YP; Nelson J; Michalopoulos G; Luo JH Am J Pathol; 2013 Mar; 182(3):796-805. PubMed ID: 23313748 [TBL] [Abstract][Full Text] [Related]
35. MCM7 serves as a prognostic marker in diffuse-type gastric adenocarcinoma and siRNA-mediated knockdown suppresses its oncogenic function. Kang W; Tong JH; Chan AW; Cheng AS; Yu J; To K Oncol Rep; 2014 May; 31(5):2071-8. PubMed ID: 24647462 [TBL] [Abstract][Full Text] [Related]
36. Role of tesmin expression in non-small cell lung cancer. Grzegrzolka J; Olbromski M; Gomulkiewicz A; Piotrowska A; Glatzel-Plucinska N; Ratajczak K; Sputa-Grzegrzolka P; Rzechonek A; Werynska B; Podhorska-Okolow M; Dziegiel P Oncol Lett; 2021 Jan; 21(1):48. PubMed ID: 33281959 [TBL] [Abstract][Full Text] [Related]
37. Endogenous MCM7 microRNA cluster as a novel platform to multiplex small interfering and nucleolar RNAs for combinational HIV-1 gene therapy. Chung J; Zhang J; Li H; Ouellet DL; DiGiusto DL; Rossi JJ Hum Gene Ther; 2012 Nov; 23(11):1200-8. PubMed ID: 22834872 [TBL] [Abstract][Full Text] [Related]
38. Minichromosome maintenance protein MCM7 is a direct target of the MYCN transcription factor in neuroblastoma. Shohet JM; Hicks MJ; Plon SE; Burlingame SM; Stuart S; Chen SY; Brenner MK; Nuchtern JG Cancer Res; 2002 Feb; 62(4):1123-8. PubMed ID: 11861392 [TBL] [Abstract][Full Text] [Related]
39. RACK1 promotes lung cancer cell growth via an MCM7/RACK1/ Akt signaling complex. Fei L; Ma Y; Zhang M; Liu X; Luo Y; Wang C; Zhang H; Zhang W; Han Y Oncotarget; 2017 Jun; 8(25):40501-40513. PubMed ID: 28465488 [TBL] [Abstract][Full Text] [Related]
40. Interaction of integrin-linked kinase and miniature chromosome maintenance 7-mediating integrin {alpha}7 induced cell growth suppression. Han YC; Yu YP; Nelson J; Wu C; Wang H; Michalopoulos GK; Luo JH Cancer Res; 2010 Jun; 70(11):4375-84. PubMed ID: 20460506 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]